News
COMISAIR: CGM ‘makes the difference’ in type 1 diabetes
BARCELONA –
News
RISE analyses highlight further youth vs. adult T2D differences
BARCELONA – New data delve further into the differences in insulin sensitivity and glucose response in youth and adults with type 2 diabetes.
News
CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine
BARCELONA – The primary endpoint of the study was not met, thus differences between the long-acting insulins could not be confirmed.
News
Filgotinib fares well in RA trial of inadequate methotrexate responders
MADRID – The investigational oral Janus kinase (JAK) 1 inhibitor filgotinib helped more patients achieve an ACR20 response at 12 weeks than did...
News
First adult APS recommendations released by European society
MADRID – The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new...
News
Abatacept response in seropositive RA may be linked to HLA gene
MADRID – Patients who had the shared epitope in HLA-DRB1 had better responses to abatacept than adalimumab in the phase 4 Early AMPLE trial.
News
Recognize and assess RA fatigue routinely, rheumatology experts urge
MADRID – Fatigue is a common and persistent problem affecting up to 80% of patients with rheumatoid arthritis and is severe in half of cases.
News
Mechanism does not matter for second-line biologic choice in JIA
MADRID – There was no difference in effectiveness outcomes or drug survival when switching to a second biologic with an alternate mechanism of...
News
Tildrakizumab shows positive effects in active psoriatic arthritis
MADRID – Already approved as a treatment for chronic plaque psoriasis, tildrakizumab (Ilumya) may also be beneficial in psoriatic arthritis,...
News
Repeated ANA testing after negative result of little diagnostic value
MADRID – In a retrospective analysis, 79% of repeated antinuclear antibody tests for ANA-associated rheumatologic conditions remained the same....
Video
RNase drug shows promise for Sjögren’s fatigue
MADRID – RSLV-132 improved fatigue symptoms in patients with primary Sjögren’s syndrome in the phase 2, randomized, proof-of-concept RESOLVE study...
News
Quality standards aim to improve worldwide spondyloarthritis care
MADRID – The Assessment of SpondyloArthritis international Society (ASAS) has developed nine new quality standards to improve the management of...
Video
Genetic variant could dictate rituximab response in lupus
MADRID – Genetic polymorphism in the Fc gamma receptor could be the reason why some patients with systemic lupus erythematosus do not respond to...